TREATMENT READING
Pancreatic Neuroendocrine Tumors (Islet Cell Tumors)
Choose a source section by treatment, subtype or setting. Patient and professional reading are labelled separately.
Selected text from the National Cancer Institute, with original links and dates. This Triangle reading page is not an NCI PDQ summary. Source topics may be broader than an individual diagnosis.
Explore 4 related disease and treatment settings → · Source-derived catalogue; clinical review pending.
Certain factors affect prognosis (chance of recovery) and treatment options.
The plan for cancer treatment depends on where the NET is found in the pancreas and whether it has spread.
Pancreatic NETs can recur (come back) after they have been treated.
Treatment Option Overview
Key Points
There are different types of treatment for patients with pancreatic NETs.
The following types of treatment are used:
Surgery
Chemotherapy
Hormone therapy
Hepatic arterial occlusion or chemoembolization
Targeted therapy
Supportive care
New types of treatment are being tested in clinical trials.
Treatment for pancreatic neuroendocrine tumors may cause side effects.
Patients may want to think about taking part in a clinical trial.
Patients can enter clinical trials before, during, or after starting their cancer treatment.
Follow-up tests may be needed.
Treatment of Gastrinoma
Treatment of Insulinoma
Treatment of Glucagonoma
Treatment of Other Pancreatic Neuroendocrine Tumors (Islet Cell Tumors)
Treatment of Recurrent or Progressive Pancreatic Neuroendocrine Tumors (Islet Cell Tumors)
Preserved source evidence · Independent clinical review pending · Not medical advice
Triangle